No Detectable Improvements in Cystic Fibrosis Transmembrane Conductance Regulator by Nasal Aminoglycosides in Patients with Cystic Fibrosis with Stop Mutations

Cystic fibrosis (CF) is an autosomal recessive disorder caused by many types of genetic defects, including premature stop codons. Gentamicin can suppress stop mutations in CF transmembrane conducatnce regulator (CFTR) in vitro and in vivo, leading to improvements in CFTR-dependent ion transport and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Clancy, John P., Rowe, Steven M., Bebok, Zsuzsa, Aitken, Moira L., Gibson, Ron, Zeitlin, Pam, Berclaz, Pierre, Moss, Rick, Knowles, Michael R., Oster, Robert A., Mayer-Hamblett, Nicole, Ramsey, Bonnie
Formato: Artigo
Idioma:Inglês
Publicado em: American Thoracic Society 2007
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1899350/
https://ncbi.nlm.nih.gov/pubmed/17347447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1165/rcmb.2006-0173OC
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados